Serum level of interleukin-6 is increased in nivolumab-associated psoriasiform dermatitis and tumor necrosis factor-α is a biomarker of nivolumab recativityRyota Tanaka, Manabu Fujimoto, Mikio Ohtsuka et al.|Journal of Dermatological Science|2016Cited by 132
The wound/burn guidelines – 6: Guidelines for the management of burnsYuichiro Yoshino, Hironobu Ihn, Mikio Ohtsuka et al.|The Journal of Dermatology|2016Cited by 78
Nivolumab-induced thyroid dysfunctionRyota Tanaka, Manabu Fujimoto, Yasuhiro Fujisawa et al.|Japanese Journal of Clinical Oncology|2016Cited by 47